WHITLEY WRIGHT: Open Payments
NPI 1396471223 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 37 payments from 11 companies in 2025. Trend: 2023 $407 · 2024 $2,747 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $150 |
| Vanda Pharmaceuticals Inc. | 11 | $135 |
| Neuronetics, Inc. | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Supernus Pharmaceuticals, Inc. | 1 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Alkermes, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, HETLIOZ, NEUROSTAR TMS THERAPY SYSTEM, SPRAVATO, REXULTI, Qelbree, INGREZZA, LYBALVI.
Industry payments across TN — which companies pay providers there.
